Industry: Pharmaceuticals, Biotechnology
Gradipore (ASX Code: GDP) is a global biotechnology company that researches, develops, manufactures and markets hematological and separation technologies principally to provide increased efficiency for research and development for the life science market throughout the world. The company’s mission is to become the global technology leader by setting new standards of performance in biological separations. In the laboratory setting, the company’s Gradiflow technology is used in conjunction with its line of electrophoresis gels, marketed as iGels ,and LongLife Gels, essential scientific laboratory measuring tools used in most biochemical separations. ( www.gradipore.com )
Gradipore Limited
22 Rodborough Road
Frenchs Forest, New South Wales 2086
Australia
Tel: +79 01 001 145